Skip to main content

Table 1 Propensity-matched patient and disease characteristics

From: Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis

  SM (n = 89) Control (n = 89) P Value
Age (years) 65.9 (59.2 – 70.1) 66.4 (59.2 – 71.9) 0.58
Female (%) 28.1 25.8 0.74
Body mass index (kg/m2) 27.1 (24.9 – 30.7) 27.1 (24.7 – 30.2) 0.81
Ejection fraction <30% 5.6 4.5 0.73
Triple-vessel disease (%) 75.3 74.2 0.86
Left main stem disease (%) 23.6 24.7 0.86
Angina class IV (%) 19.1 14.6 0.42
Diabetes (%) 23.6 29.2 0.39
Respiratory disease (%) 37.1 33.7 0.64
Renal dysfunction (%) 6.7 5.6 0.76
Peripheral vascular disease (%) 9.0 7.9 0.79
Current smoker (%) 20.2 20.2 >0.99
Previous myocardial infarction (%) 46.1 51.7 0.45
Hypercholesterolaemia (%) 95.5 95.5 >0.99
Hypertension (%) 57.3 55.1 0.76
Emergent procedure (%) 1.1 1.1 >0.99
Preoperative β-blockers (%) 66.3 64.0 0.75
Preoperative diuretics (%) 33.7 36.0 075
Preoperative heart rate (bpm) 69.1 (61.8 – 81.9) 70.3 (60.6 – 83.2) 0.57
Additive EuroSCORE 4 (2 – 5) 3 (2 – 5) 0.63
Number of grafts (n/patient) 3 (2 – 4) 3 (3 – 4) 0.61
Right-CAD (%) 76.4 71.9 0.49
LIMA (%) 95.5 96.6 0.69
CPB not used (%) 77.5 69.7 0.23
  1. SM, Sotalol and Magnesium; CPB, Cardiopulmonary Bypass; EuroSCORE, European System for Cardiac Operative Risk Evaluation; CAD, Coronary Artery Disease; LIMA, Left Internal Mammary Artery. Categorical variables are shown as a percentage. Continuous variables are shown as a median with 25th and 75th percentiles.